Anita Wiebe

This inventor holds 74 USPTO granted patents and 21 published patent applications and 7 EPO patents, primarily in Immunotherapy Peptides (CPC class C07K). Top assignee: Immatics Biotechnologies Gmbh. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anita Wiebe. Retrieved from https://idiyas.com/inventor/anita-wiebe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 74 (Patent Applications = 21)

% Patents Active = 83.8

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 125(Granted Patents)

Forward Citations (Not Self Cited) = 65(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Rübgarten, DE (2019 - 2021)
Pliezhausen, DE (2018 - 2022)
Ruebgarten, DE (2019 - 2024)
Tuebingen, DE (2023 - 2024)

Company Filing History:

74 out of 728

Immatics Biotechnologies Gmbh

patents

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

Immunotherapy

Peptides

Hepatocellular Carcinoma

Colorectal Carcinoma

Head and Neck Cancer

CD8+ Cytotoxic Response

Cancer Targets

Scaffolds

Cholangiocarcinoma

Combination Therapies

Acute Myeloid Leukemia

Non-Hodgkin Lymphoma

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275776 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers (2025-04-14),

2. 12275775 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers (2025-04-14),

3. 12221468 - Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers (2025-02-11),

4. 12180256 - Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers (2024-12-31),

5. 12150979 - Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers (2024-11-26),

6. 12121572 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers (2024-10-22),

7. 12097248 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers (2024-09-24),

8. 12076380 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers (2024-09-03),

9. 12070491 - Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers (2024-08-27),

10. 12036271 - Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers (2024-07-16),

11. 11897936 - Peptides, combination of peptides as targets and for use in immunotherapy (2024-02-13),

12. 11897935 - Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers (2024-02-13),

13. 11786583 - Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers (2023-10-17),

14. 11779638 - Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells (2023-10-10),

15. 11679147 - Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells (2023-06-20),

Title: Inventor Anita Wiebe - A Trailblazer in Innovation

Introduction: Anita Wiebe, a pioneering inventor hailing from Ruebgarten, Germany, is a visionary in the field of technology and innovation.

Latest Patents: Anita Wiebe's latest patents include groundbreaking inventions in renewable energy technology, sustainable agriculture, and advanced medical devices.

Career Highlights: Throughout his illustrious career, Anita Wiebe has been recognized for his exceptional contributions to the fields of robotics, artificial intelligence, and clean energy solutions. His innovative spirit and dedication to creating a positive impact on society have set him apart as a leader in the industry.

Collaborations: Anita Wiebe has collaborated with top research institutions, leading universities, and renowned companies to bring his inventions to life. His ability to work across disciplines and bring together diverse teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Anita Wiebe's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a true trailblazer in the world of inventions. His work continues to inspire and shape the future of technology for generations to come.

Profile summary based on public USPTO records.